Various therapeutic methods and molecules, such as electroacupuncture therapy, CD33, thyroid hormone, cyclic GMP-AMP synthase, and rapamycin, have demonstrated efficacy in modulating AD progression via TREM2 regulation [311–319]. This evidence concerns the gene CD33 and Alzheimer disease.